Log inSign up
Reading a stock page
  • The tabs show the price chart, results, shareholding, events and news for this one company.
  • The Signal Score sums up trend, momentum and quality from past data. It is a description, not a forecast.
  • Every figure names its source. "Official" means it came from NSE or BSE filings.
  • Use the star to watch the stock, or Add to portfolio to record a trade.

Prices during market hours are delayed by up to 15 minutes. Nothing here is a recommendation to buy or sell.

« Dashboard

BALAXI ☆ NSE

BALAXI PHARMA LTD · code 11309 · INE618N01022 · Pharma & Healthcare · series EQ · Daily price history

37.30 +5.65 (+17.85%) close on 19 Nov 2026
Official NSE & BSE Auto-Sync: Checking Overview, Financials, Technicals, Shareholding & Events in the background...
63

ISA Signal Score: Positive

Looks healthy: accumulate on dips or hold. Based on prices to 2026-11-19. Confidence 100%.

Trend78
Momentum72
52-week range93
Volume95
Risk25
Fundamentals36

Working for it

  • Price is above its 20-day average
  • Price is above its 50-day average
  • Price is above its 200-day average (long-term uptrend)
  • MACD is positive and strengthening
  • Up 57% in 3 months
  • Within 4% of its 52-week high

Working against it

  • 50-day average is below the 200-day average
  • RSI 86: overbought, a pullback is more likely
  • Profit fell 96% year on year
  • Revenue fell 8% year on year

Red flags

  • Extreme one-day move (+17.9%): check the news before acting
  • Profit fell sharply (96%)

Measured reference levels (not forecasts): 20-day low 19.15, 52-week high 38.97, typical daily move 2.31, two typical moves below price 32.69.

A rule-based reading of price, volume and filed numbers. It is information, not investment advice, and it can be wrong. Do your own research.

At a glance

Five quick readings from results and prices. A starting point for your own research, not advice.
QualityWeakROE 0.4%, ROCE 3.4%, debt 0.23x equity
GrowthSlowSales -0.8%, profit -62.0% a year over 4 years
ValuationExpensiveP/E 143.5 vs sector median 42.8
MomentumStrongAbove its 200-day average, beat NIFTY 50 by 5.7 points
RiskHighSwings 60% a year, fell up to 59% from a peak, beta 1.05

Smart Investor Tips: BALAXI

Balanced / Watch for Key Level Confirmation

Actionable Insights & Positives

  • Tip: Click the star button above to add this stock to your Watchlist and set a target "Buy below" alert price.

Risk Checks & Things to Verify

  • RSI is elevated at 86 (overbought territory > 70). Avoid chasing gap-ups; let momentum cool or consolidate.
  • Premium valuation: P/E of 143.5x vs sector median 42.8x leaves less margin of safety if growth slows.
  • High 30-day annualized volatility (103%). Keep initial position sizes smaller and use wider stop-review levels.

NSE MCP Live & 5-Year Check No API Key

Connects directly to NSE's official Model Context Protocol servers (cm-market for live 1–3 min delayed quote & nse-bhavcopy for 52W range, 20/50/200 DMA, 20-day volume surge, and corporate actions), and syncs missing sessions into your database.

Algorithmic Buy / Sell Prediction & Optimal Entry PriceAVOID / REDUCE ON BOUNCES (Score 40/100)

Weak trend, debt overhang, or distribution. Avoid fresh buying until price reclaims 50-DMA (Rs 22.76). If already held, protect capital if it breaks below Rs 19.07 or trim near resistance Rs 37.98.

Optimal Buy ZoneTranche 1 (50%)Tranche 2 (50%)Stop-Loss / ReviewTarget 1 (Swing)Target 2 (Breakout)Risk : Reward
Rs 22.53 – Rs 23.44
Ideal ~Rs 22.99
Rs 23.44 Rs 22.53 Rs 19.07
ATR 6.2%
Rs 37.98 Rs 40.98 1 : 3.8
RSI 90 · Vol 26.13x
1M 3M 6M 1Y 3Y ALL Investment checklist Download CSV 6M change +51.7% · high 37.98 · low 18.70 · max drawdown -26.9%

Live Candlestick & TradingView Chart (BALAXI)

MARKET CLOSED - EOD SNAPSHOT
Style:  Timeframe:  Overlays:

Key figures results FY26, price 19 Nov

P/E143.5sector median 42.8
P/B-price / book value
EPSRs 0.26grew -59.4% a year
Dividend yield-from saved dividend events
Debt to equity0.23xnet debt Rs 58.0 Cr
Sales growth-0.8%a year over 4 years
Profit growth-62.0%a year over 4 years
Operating margin3.3%net margin 0.4%

From the official NSE results filings, consolidated. P/E uses the last full year's EPS. See all years.

Company Debt, Borrowings & Cash Flow Health (Official FY26 Consolidated Filing)

Auto-extracted from official NSE/BSE XBRL Balance Sheet & Cash Flow statements (Rs Crore).

Adequate Debt & Cash Position · Score 55/100
Total Debt / Loans Rs 58.0 Cr Increased +Rs 5.00 Cr YoY
Cash & Bank Balances - Liquid cash & equivalents
Net Debt (Loans − Cash) Rs 58.0 Cr 17.2% of total assets
Debt to Equity & Interest Cover 0.23x D/E Interest cover: 2.0x EBIT
Operating Cash Flow (OCF) Rs -4.00 Cr OCF/PAT conversion: -400%
Free Cash Flow (FCF) - OCF minus Capex
  • Low Debt-to-Equity (0.23x).
  • Weak cash conversion (-7% OCF/PAT) - profits are tied up in receivables or inventory.

About BALAXI PHARMA

No company description saved yet. Use Profile below to read about this company.

Listed on NSE

Market capNot available
First listed30 Nov 2015NSE 30 Nov 2015
Face valueRs 2
Book valueNot available
ROENot availableReturn on equity
ROCENot availableReturn on capital employed

NSE: listing date, face value

Profile completeness2 of 8Missing: description, industry, share count, book value, ROE, ROCE

Checked: NSE results 19 Nov 2026.

Profile, History and Financial records open a web search for this company in a new tab.

Shareholding

Promoters and group 65.99% 0.00 pp, public 34.01%, as on 30 Sep 2026. Holder names and history

Day range31.80 to 37.98Open 31.80
52-week high40.98 -9.0% from high (20 Nov 2025)
52-week low15.20 +145.4% from low (27 Mar 2026)
Volume32.71 L 26.8x the 20-day average
RSI (14)86 overbought
Volatility (30d)102.5%annualised
15.20
40.98

Returns

1W+56.5%
1M+71.4%
3M+67.3%
6M+49.0%
1Y+3.7%
YTD+38.8%
3Y a year-55.2%
5Y a year-41.7%

Against the NIFTY 50

PeriodBALAXINIFTY 50Difference
1M+71.4%+11.5% +59.9 pts
3M+67.3%+5.3% +62.0 pts
6M+49.0%+7.9% +41.1 pts
1Y+3.7%-2.1% +5.7 pts

Risk over the past year

Volatility60%high
Deepest fall-59.0%from a peak
Beta1.05moves with the index
Best day+20.0%17 Nov 2026
Worst day-9.0%12 Dec 2025
Up days47%of sessions

Returns use closing prices. Bonus issues and splits are adjusted automatically when detected. Beta compares daily moves with the NIFTY 50 over 246 shared sessions.

AI analysis

Company turnover, products, risks and entry ideas, written by the AI provider you set up in Settings.

Open AI analysis

🛡 Forensic Financial Health: Piotroski F-Score & 3-Step DuPont ROE Decomposition

Institutional balance-sheet quality, earnings-to-cash conversion, and ROE driver breakdown from official XBRL filings.

Piotroski F-Score: 3 / 9 · Weak / Watch Balance Sheet
3-Step DuPont ROE Identity: Balanced Profitability & Efficiency
Net Margin: 0.4% × Asset Turnover: 0.80x × Equity Multiplier: 1.35x = ROE 0.4%
✓ Positive Net Profit (PAT > 0) Rs 1.00 Cr
⚠ Positive Operating Cash Flow (OCF > 0) Rs -4.00 Cr
⚠ High Cash Conversion (OCF >= 85% of PAT) -400% conversion
⚠ Improving Return on Assets (ROA YoY) 0.3% vs 8.1%
✓ Conservative / Decreasing Debt-to-Equity 0.23x (prev 0.23x)
✓ Healthy Balance Sheet Asset Coverage 11.23x
⚠ Institutional Return on Equity (ROE >= 14%) 0.4%
⚠ Stable / Expanding Profit Margin YoY 0.4% vs 8.5%
⚠ Asset Turnover Efficiency (Sales / Assets) 0.80x

Quarterly Results (Last 8 Quarters — QoQ & YoY Acceleration) Rs crore

Rs crore Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
Sales / Revenue 11.276.370.756.272.570.780.781.4
Sales QoQ % -47.3%+583.4%-7.3%-20.6%+29.1%-2.5%+14.1%+0.9%
Operating Profit 0.0912.64.161.163.090.124.665.13
Operating Margin (OPM %) 0.8%16.5%5.9%2.1%4.3%0.2%5.8%6.3%
Net Profit (PAT) 1.748.640.290.210.310.611.301.15
Profit QoQ % +4.8%+396.6%-96.6%-27.6%+47.6%+96.8%+113.1%-11.5%
Profit YoY % +255.1%+1589.7%-79.0%-87.3%-82.2%-92.9%+348.3%+447.6%
Net Margin % 15.6%11.3%0.4%0.4%0.4%0.9%1.6%1.4%

Sales and profit Rs crore, consolidated

Sales growth-0.8%a year, 4Y
Profit growth-62.0%a year, 4Y
EPS growth-59.4%a year, 4Y
Avg ROE10.9%5 years

Profit and loss

Rs croreFY22FY23FY24FY25FY26
Sales279336241293270
Sales growth-+20.6%-28.3%+21.4%-7.8%
Operating profit52.056.58.4539.09.00
Operating margin18.6%16.8%3.5%13.3%3.3%
Other income5.002.64-2.65-4.003.00
Interest1.000.501.684.005.00
Depreciation1.001.752.102.002.00
Profit before tax55.056.92.0229.05.00
Tax rate13.0%19.3%217.8%13.0%73.0%
Net profit48.00025.01.00
Profit growth--100.0%---96.0%
Net margin17.2%0.0%0.0%8.5%0.4%
EPS (Rs)9.5345.81-2.324.540.26

Balance sheet

Rs croreFY22FY23FY24FY25FY26
Equity (net worth)113183201232249
Borrowings4.0011.617.753.058.0
Cash-28.262.3--
Total assets176240258310337
Debt to equity0.04x0.06x0.09x0.23x0.23x

Debt, Loans, Cash Flow & Working Capital

Rs croreFY22FY23FY24FY25FY26
Operating Cash Flow (OCF)34.06.084.87-35.0-4.00
Capital Expenditure (Capex)-10.80.69--
Free Cash Flow (FCF = OCF - Capex)--4.724.18--
OCF / Net Profit Conversion0.71x---1.40x-4.00x
Total Borrowings / Loans4.0011.617.753.058.0
Cash & Bank Balances-28.262.3--
Trade Receivables (Cr)-53.455.7--
Receivable Days-57.97x84.27x--
Inventories (Cr)-10582.2--
Inventory Days-113.94x124.30x--

Returns on capital

Rs croreFY22FY23FY24FY25FY26
ROE42.5%0.0%0.0%11.5%0.4%
ROCE48.3%38.0%1.9%13.5%3.4%
Interest cover56.00x114.84x2.20x8.25x2.00x

Read from the official annual results filed with NSE (XBRL), consolidated figures. ROE uses average equity of the year and the year before when both are saved, ROCE uses profit before interest and tax over total assets less current liabilities. EPS is per today's share. Check the annual report before investing.

Compared with its sector Pharma & Healthcare

StockPriceDay1 yearMkt cap (Cr)P/EP/BROENet margin
ALIVUSALIVUS LIFE SCIENCES LTD 1,449.90 +0.4% - 17,769 37.7 7.6 20.2% 20.6%
AARTIPHARMAARTI PHARMALABS LIMITED 1,024.60 +1.1% - 9,285 42.8 5.3 12.3% 11.7%
BLUEJETBLUE JET HEALTHCARE LTD 516.85 -0.3% - 8,965 54.8 10.6 19.4% 23.0%
AARTIDRUGSAARTI DRUGS LTD. 498.90 -1.4% - 4,587 26.9 3.6 13.4% 6.8%
DIVISLABDIVI S LABORATORIES LTD 11,178.00 +1.2% - - - - - -
WOCKPHARMAWOCKHARDT LIMITED 2,187.00 +7.9% - - - - - -
LAURUSLABSLAURUS LABS LIMITED 2,306.00 -0.7% - - - - - -
SUNPHARMASUN PHARMACEUTICAL IND L 1,900.00 +1.5% - - - - - -
MAXHEALTHMAX HEALTHCARE INS LTD 1,040.65 +1.7% - - - - - -
CIPLACIPLA LTD 1,418.50 +0.1% - - - - - -
APOLLOHOSPAPOLLO HOSPITALS ENTER. L 8,738.00 -0.9% - - 64.7 - 21.1% 7.9%
DRREDDYDR. REDDY S LABORATORIES 1,400.90 +0.2% - - - - - -
BALAXIBALAXI PHARMA LTD 37.30 +17.9% - - 143.5 - 0.4% 0.4%
Sector median- 42.86.513.4%

The 13 largest of 80 stocks in this sector on NSE, by market cap where known and traded value otherwise. Valuation shows for stocks whose results this site has read; it fills in as people open more stock pages. Prices from 19 Nov 2026.

Today: 15 minute chart and signal

Opens when you view this tab.

Analysis and next-session reading

Opens when you view this tab.

Complete analysis report Financials, shareholding, events, risks and a data reliability score.

Signals

Price is above its 50-day average 20-day average is above the 50-day (short-term uptrend) Price is above its 200-day average (long-term uptrend) RSI 86: overbought zone, a pullback is more likely Volume is 26.8x the 20-day average

Simple rules applied to end-of-day prices. They describe what the chart is doing and are not advice to buy or sell.

When is a good price? from this stock's own price history

The price is in the upper quarter of its 1-year range and is lower than it was on 2% of days in the past year.

Support (prices below today's)

200-day average23.18-37.8%
50-day average22.76-39.0%
20-day low18.70-49.9%
60-day low18.70-49.9%
52-week low15.20-59.2%

Resistance (prices above today's)

20-day high37.98+1.8%
60-day high37.98+1.8%
52-week high40.98+9.9%

Zones buyers often watch

Lower quarter of the 1-year range 15.20 to 21.65 Historically the cheapest part of the past year.
Pullback of 10% to 20% from the high 32.78 to 36.88 A common area for dips inside an uptrend.
Around the 200-day average 22.49 to 23.88 Long-term trend line, often watched as support.

Deepest fall from a peak in the past year: -59.0%. Currently -2.3% below its latest peak. Levels are from history and do not predict where the price will go.

Moving averages and momentum

IndicatorValueReading
20-day average22.77 Price is 63.8% above
50-day average22.76 Price is 63.9% above
200-day average23.18 Price is 60.9% above
RSI (14)86Overbought zone
MACD (12, 26, 9)2.17Above its signal line (momentum rising)
Volatility (30d)102.5%High yearly swings

Support and resistance

R241.87
R139.59
Pivot35.69
S133.41
S229.51

Classic pivot levels from the latest session's high, low and close. Prices often pause near them, but they are only reference points.

DateOpenHighLow CloseChangeVolume
2026-11-19 31.80 37.98 31.80 37.30 +17.85% 3,270,918
2026-11-18 30.00 31.76 27.80 31.65 +19.57% 1,769,148
2026-11-17 22.40 26.47 22.40 26.47 +19.99% 248,665
2026-11-16 23.60 23.60 21.80 22.06 -5.89% 16,771
2026-11-13 23.99 23.99 22.50 23.44 -1.68% 14,070
2026-11-12 23.08 25.55 22.70 23.84 +5.16% 69,337
2026-11-11 22.70 23.44 22.40 22.67 +0.04% 24,904
2026-11-09 22.64 23.00 21.85 22.66 +1.43% 16,632
2026-11-06 22.40 22.40 21.30 21.96 +0.32% 12,945
2026-11-05 20.90 22.35 20.77 21.89 +6.78% 17,898
2026-11-04 19.75 21.00 19.75 20.50 +1.18% 7,784
2026-11-03 19.75 20.92 19.37 20.26 +2.58% 8,509
2026-11-02 19.60 19.99 19.21 19.75 +3.13% 6,108
2026-10-30 19.99 19.99 18.70 19.15 -2.84% 21,377
2026-10-29 20.60 20.60 19.16 19.71 -3.05% 31,016
2026-10-28 20.22 21.20 19.80 20.33 +0.59% 16,375
2026-10-27 20.00 20.47 20.00 20.21 +2.59% 12,072
2026-10-26 21.10 21.10 19.50 19.70 -5.79% 24,393
2026-10-23 21.18 21.18 19.35 20.91 -0.43% 40,139
2026-10-22 21.10 21.30 19.16 21.00 -0.47% 62,006
2026-10-21 22.35 22.35 21.00 21.10 -3.03% 23,032
2026-10-19 22.09 22.34 21.60 21.76 -1.49% 19,900
2026-10-16 22.60 22.60 21.80 22.09 -0.18% 13,444
2026-10-15 22.40 22.62 21.85 22.13 -0.23% 10,714
2026-10-14 22.40 22.40 21.70 22.18 -0.05% 8,605
2026-10-13 22.58 22.58 21.50 22.19 -0.76% 26,229
2026-10-12 22.33 22.90 22.30 22.36 +0.13% 16,602
2026-10-09 22.40 22.79 22.09 22.33 +1.09% 13,772
2026-10-08 22.81 23.40 21.05 22.09 -1.30% 61,447
2026-10-07 22.95 23.49 22.22 22.38 -1.28% 15,155
2026-10-06 23.00 23.00 22.32 22.67 -0.44% 8,384
2026-10-05 22.06 23.05 22.06 22.77 +1.92% 22,927
2026-10-01 23.19 23.19 22.20 22.34 -1.93% 20,508
2026-09-30 23.40 23.40 22.55 22.78 -1.04% 11,994
2026-09-29 22.39 23.45 22.05 23.02 +2.81% 18,116
2026-09-28 23.27 23.27 21.00 22.39 -1.88% 48,102
2026-09-25 22.43 23.28 22.43 22.82 +0.40% 11,304
2026-09-24 22.50 23.25 22.50 22.73 -0.92% 20,375
2026-09-23 23.12 23.58 22.42 22.94 -0.78% 81,169
2026-09-22 23.50 23.50 22.96 23.12 -1.24% 22,486
2026-09-21 23.55 24.00 23.10 23.41 -0.59% 7,765
2026-09-18 22.70 23.60 22.70 23.55 +2.21% 17,900
2026-09-17 23.60 23.60 22.40 23.04 -1.24% 24,054
2026-09-16 23.01 24.33 22.50 23.33 +0.91% 19,590
2026-09-15 24.80 24.80 23.00 23.12 -1.15% 26,067
2026-09-11 23.40 24.69 22.75 23.39 +0.65% 39,705
2026-09-10 24.20 24.36 22.73 23.24 -1.86% 39,290
2026-09-09 24.18 25.05 22.70 23.68 +1.46% 87,548
2026-09-08 24.24 24.75 23.20 23.34 -3.71% 67,891
2026-09-07 26.00 26.00 23.50 24.24 -4.45% 69,369
2026-09-04 26.60 26.60 24.93 25.37 -1.67% 50,780
2026-09-03 26.99 26.99 24.41 25.80 +3.16% 222,864
2026-09-02 22.45 25.04 22.45 25.01 +9.84% 302,797
2026-09-01 22.35 23.10 22.35 22.77 +1.92% 22,106
2026-08-31 22.54 23.00 22.01 22.34 -0.89% 21,366
2026-08-28 22.10 22.90 22.10 22.54 +0.45% 13,533
2026-08-27 22.30 22.94 22.30 22.44 +0.13% 6,825
2026-08-26 23.40 23.40 22.06 22.41 -1.84% 10,631
2026-08-25 23.35 23.35 22.31 22.83 +0.09% 10,635
2026-08-24 22.85 23.50 22.41 22.81 +1.83% 21,796
2026-08-21 22.40 23.00 22.24 22.40 +0.45% 50,714
2026-08-20 24.20 24.20 21.50 22.30 -6.26% 139,295
2026-08-19 24.25 24.30 23.32 23.79 +0.30% 30,405
2026-08-18 24.21 24.25 23.70 23.72 -2.02% 27,297
2026-08-17 24.20 24.25 23.65 24.21 +0.88% 27,550
2026-08-14 23.60 24.23 23.53 24.00 +0.04% 25,968
2026-08-13 23.93 24.20 23.75 23.99 -0.25% 45,780
2026-08-12 23.76 24.20 23.50 24.05 +1.69% 11,702
2026-08-11 24.44 24.49 23.60 23.65 -2.27% 39,143
2026-08-10 24.70 24.70 24.00 24.20 -0.49% 23,098
2026-08-07 24.18 24.75 24.00 24.32 +0.50% 16,200
2026-08-06 24.55 24.80 24.17 24.20 +0.12% 35,022
2026-08-05 24.03 25.40 23.80 24.17 +0.58% 90,450
2026-08-04 24.65 24.65 23.72 24.03 +0.13% 23,587
2026-08-03 23.67 24.75 23.67 24.00 +0.42% 13,887
2026-07-31 24.63 24.80 23.88 23.90 -2.49% 36,557
2026-07-30 24.80 25.50 24.00 24.51 +1.53% 45,022
2026-07-29 24.20 24.75 24.00 24.14 -1.23% 11,774
2026-07-28 24.02 24.79 24.00 24.44 +0.21% 22,411
2026-07-27 24.97 24.97 24.00 24.39 -0.33% 10,773
2026-07-24 24.42 24.49 24.00 24.47 +0.20% 14,058
2026-07-23 24.12 24.50 23.60 24.42 +1.75% 15,527
2026-07-22 24.20 24.20 23.58 24.00 +1.78% 15,559
2026-07-21 23.58 24.20 23.50 23.58 -1.83% 19,335
2026-07-20 23.59 24.19 23.58 24.02 +1.48% 14,576
2026-07-17 23.01 24.50 23.00 23.67 -0.67% 49,128
2026-07-16 24.75 24.75 23.82 23.83 -1.12% 28,502
2026-07-15 24.20 24.50 24.00 24.10 -0.12% 9,948
2026-07-14 24.04 24.45 23.50 24.13 +0.37% 28,651
2026-07-13 24.45 24.50 23.61 24.04 -0.54% 11,826
2026-07-10 24.02 24.27 24.00 24.17 +0.62% 8,164
2026-07-09 24.20 24.20 23.31 24.02 +0.08% 15,903
2026-07-08 23.85 24.49 23.37 24.00 +0.63% 29,314
2026-07-07 24.00 24.80 23.62 23.85 -0.62% 33,906
2026-07-06 24.48 24.59 23.61 24.00 +1.39% 16,895
2026-07-03 24.13 24.95 23.61 23.67 -1.91% 36,382
2026-07-02 24.00 24.40 23.11 24.13 +1.69% 26,141
2026-07-01 23.87 24.35 23.50 23.73 -0.75% 15,838
2026-06-30 23.70 24.08 23.00 23.91 +1.36% 50,689
2026-06-29 23.10 23.60 22.90 23.59 +2.03% 30,448
2026-06-25 22.67 23.59 22.67 23.12 -0.30% 8,167
2026-06-24 22.90 23.70 22.50 23.19 +2.52% 52,628
2026-06-23 23.25 23.59 22.60 22.62 -1.95% 32,491
2026-06-22 23.43 24.20 23.00 23.07 -2.45% 28,814
2026-06-19 23.85 23.90 22.50 23.65 -0.08% 22,199
2026-06-18 23.27 23.91 23.25 23.67 +0.47% 9,453
2026-06-17 23.99 23.99 23.08 23.56 +0.47% 8,631
2026-06-16 24.20 24.20 23.08 23.45 -1.43% 24,303
2026-06-15 23.10 23.99 23.00 23.79 +4.11% 33,017
2026-06-12 23.70 23.70 22.50 22.85 -1.68% 34,058
2026-06-11 24.00 24.70 23.10 23.24 -4.40% 53,516
2026-06-10 24.34 24.69 23.51 24.31 +0.37% 13,818
2026-06-09 24.00 24.85 24.00 24.22 -1.14% 32,308
2026-06-08 24.45 24.98 24.00 24.50 +0.91% 16,340
2026-06-05 24.53 24.98 24.13 24.28 -1.50% 21,842
2026-06-04 24.13 25.48 24.01 24.65 -1.36% 38,086
2026-06-03 25.01 25.95 24.21 24.99 -1.73% 35,201
2026-06-02 25.96 26.01 25.00 25.43 -2.23% 27,378
2026-06-01 27.50 27.50 25.00 26.01 -0.76% 46,827
2026-05-29 24.95 26.21 24.95 26.21 +4.97% 52,623
2026-05-27 25.49 25.90 24.11 24.97 -1.58% 63,104
2026-05-26 24.99 25.80 24.53 25.37 +1.52% 25,261
2026-05-25 25.00 25.98 24.37 24.99 -0.28% 28,874
2026-05-22 24.50 25.45 24.50 25.06 +0.08% 10,604
2026-05-21 24.50 25.58 24.50 25.04 +2.25% 16,268
2026-05-20 24.35 25.43 23.89 24.49 +0.37% 12,648
2026-05-19 24.10 25.35 23.40 24.40 -0.77% 24,956
2026-05-18 25.87 25.87 24.59 24.59 -4.98% 37,426

News from the last 15 days More

Shareholding pattern

Up to dateNSE listingChecks passed

Quarter ended 30 Sep 2026, filed 17 Oct 2026. Latest filing is for the expected quarter (Sep 2026). Company: BALAXI PHARMA LTD, ISIN INE618N01022.

Promoters and group
65.99%
0.00 pp vs Jun 2026
Public (all, Category B)
34.01%
0.00 pp vs Jun 2026

Foreign, domestic institution and mutual fund lines need the filing file for the period. An admin can load them under Admin > Shareholding tracker.

Ownership split

Trend

Latest quarter compared

CategoryPrevious (Jun 26)Latest (Sep 26)Change (pp)Change in sharesYear earlier (pp)What it may mean
Promoters and group65.99%65.99%0.00 pp-0.00 ppNo material change.
Public (all, Category B)34.01%34.01%0.00 pp-0.00 ppNo material change.

Change is in percentage points (latest percent minus previous percent), not a relative change. Mutual funds and insurers are part of domestic institutions and are never added to it. Only comparable quarters (1 to 6 months apart; about a year for the year-earlier column) are compared.

Insights and risk alerts

No rule was triggered by the data in the database. That is not a clean bill of health: the rules look only at reported holdings.

These alerts describe reported ownership. They are not buy or sell advice. Judge the company with its results, debt, valuation and announcements.

Who holds the shares

The exchange listing has no filing file for this stock, so holder names are not available.

Quarter by quarter

Quarter endedPromotersChangePublicChangeFiledSource
Sep 202665.99%0.00 pp34.01%0.00 pp17 Oct 2026NSE
Jun 202665.99%0.00 pp34.01%0.00 pp21 Jul 2026NSE
Mar 2026 revised65.99%0.00 pp34.01%0.00 pp14 Apr 2026NSE
Dec 202565.99%0.00 pp34.01%0.00 pp17 Jan 2026NSE
Sep 202565.99%0.00 pp34.01%0.00 pp18 Oct 2025NSE
Jun 202565.99%0.00 pp34.01%0.00 pp20 Jul 2025NSE
Mar 202565.99%0.00 pp34.01%0.00 pp19 Apr 2025NSE
Dec 202465.99%0.00 pp34.01%0.00 pp16 Jan 2025NSE
Sep 202465.99%0.00 pp34.01%0.00 pp17 Oct 2024NSE
Jun 2024 revised65.99%-0.37 pp34.01%+0.37 pp17 Jul 2024NSE
Apr 202466.36%-0.50 pp33.64%+0.50 pp11 Apr 2024NSE
Mar 202466.86%-0.94 pp33.14%+0.94 pp12 Apr 2024NSE
Feb 202467.80%-3.42 pp32.20%+3.42 pp01 Mar 2024NSE
Dec 202371.22%0.00 pp28.78%0.00 pp09 Jan 2024NSE
Sep 202371.22%0.00 pp28.78%0.00 pp11 Oct 2023NSE
Jun 202371.22%0.00 pp28.78%0.00 pp11 Jul 2023NSE
May 202371.22%-0.35 pp28.78%+0.35 pp17 May 2023NSE
Mar 202371.57%-1.12 pp28.43%+1.12 pp14 Apr 2023NSE
Dec 202272.69%-0.17 pp27.31%+0.17 pp16 Jan 2023NSE
Sep 202272.86%0.00 pp27.14%0.00 pp17 Oct 2022NSE
Jun 202272.86%0.00 pp27.14%0.00 pp18 Jul 2022NSE
Mar 202272.86%0.00 pp27.14%+0.02 pp11 Apr 2022NSE
Dec 202172.86%0.00 pp27.12%-0.01 pp12 Jan 2022NSE
Sep 202172.86%-27.13%-18 Oct 2021NSE
Shareholding details

Loading...

Events

Not checked yet

No events saved for this stock yet.

Fetched from NSE automatically and saved on this site, so past events stay available. Ex date is the first day the stock trades without the benefit; a bonus or split is applied to old prices on its own from that day. Confirm on the exchange website before acting.

ISA shows information and signals worked out from past prices and company filings. They are not recommendations to buy, sell or hold any security, and ISA is not a SEBI-registered investment adviser or research analyst. Prices may be delayed. Check with a registered adviser before you invest.